These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 29804232)

  • 21. Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington's disease.
    Smith GA; Rocha EM; McLean JR; Hayes MA; Izen SC; Isacson O; Hallett PJ
    Hum Mol Genet; 2014 Sep; 23(17):4510-27. PubMed ID: 24728190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overcoming the inhibitors of myelin with a novel neurotrophin strategy.
    Williams G; Williams EJ; Maison P; Pangalos MN; Walsh FS; Doherty P
    J Biol Chem; 2005 Feb; 280(7):5862-9. PubMed ID: 15572360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice.
    Xie Y; Hayden MR; Xu B
    J Neurosci; 2010 Nov; 30(44):14708-18. PubMed ID: 21048129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of brain-derived neurotrophic factor (BDNF) in the functional elimination of synaptic contacts at polyinnervated neuromuscular synapses during development.
    Garcia N; Santafe MM; Tomàs M; Lanuza MA; Besalduch N; Tomàs J
    J Neurosci Res; 2010 May; 88(7):1406-19. PubMed ID: 20029969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease.
    Nguyen KQ; Rymar VV; Sadikot AF
    Front Cell Neurosci; 2016; 10():37. PubMed ID: 27013968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological Co-Activation of TrkB and TrkC Receptor Signaling Ameliorates Striatal Neuropathology and Motor Deficits in Mouse Models of Huntington's Disease.
    Simmons DA; Belichenko NP; Longo FM
    J Huntingtons Dis; 2023; 12(3):215-239. PubMed ID: 37638447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BDNF-TrkB/proBDNF-p75
    Jia D; Wang F; Bai Z; Chen X
    Sci Rep; 2023 Oct; 13(1):18364. PubMed ID: 37884604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A small molecule p75NTR ligand normalizes signalling and reduces Huntington's disease phenotypes in R6/2 and BACHD mice.
    Simmons DA; Belichenko NP; Ford EC; Semaan S; Monbureau M; Aiyaswamy S; Holman CM; Condon C; Shamloo M; Massa SM; Longo FM
    Hum Mol Genet; 2016 Nov; 25(22):4920-4938. PubMed ID: 28171570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A monoclonal antibody TrkB receptor agonist as a potential therapeutic for Huntington's disease.
    Todd D; Gowers I; Dowler SJ; Wall MD; McAllister G; Fischer DF; Dijkstra S; Fratantoni SA; van de Bospoort R; Veenman-Koepke J; Flynn G; Arjomand J; Dominguez C; Munoz-Sanjuan I; Wityak J; Bard JA
    PLoS One; 2014; 9(2):e87923. PubMed ID: 24503862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice.
    Gharami K; Xie Y; An JJ; Tonegawa S; Xu B
    J Neurochem; 2008 Apr; 105(2):369-79. PubMed ID: 18086127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease.
    Pineda JR; Canals JM; Bosch M; Adell A; Mengod G; Artigas F; Ernfors P; Alberch J
    J Neurochem; 2005 Jun; 93(5):1057-68. PubMed ID: 15934928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased BDNF Release in Cortical Neurons of a Knock-in Mouse Model of Huntington's Disease.
    Yu C; Li CH; Chen S; Yoo H; Qin X; Park H
    Sci Rep; 2018 Nov; 8(1):16976. PubMed ID: 30451892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration.
    Strand AD; Baquet ZC; Aragaki AK; Holmans P; Yang L; Cleren C; Beal MF; Jones L; Kooperberg C; Olson JM; Jones KR
    J Neurosci; 2007 Oct; 27(43):11758-68. PubMed ID: 17959817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fine-tuning roles of endogenous brain-derived neurotrophic factor, TrkB and sortilin in colorectal cancer cell survival.
    Akil H; Perraud A; Mélin C; Jauberteau MO; Mathonnet M
    PLoS One; 2011; 6(9):e25097. PubMed ID: 21966426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TrkB/BDNF-dependent striatal plasticity and behavior in a genetic model of epilepsy: modulation by valproic acid.
    Ghiglieri V; Sgobio C; Patassini S; Bagetta V; Fejtova A; Giampà C; Marinucci S; Heyden A; Gundelfinger ED; Fusco FR; Calabresi P; Picconi B
    Neuropsychopharmacology; 2010 Jun; 35(7):1531-40. PubMed ID: 20200504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6/2 mouse model of Huntington's disease.
    Samadi P; Boutet A; Rymar VV; Rawal K; Maheux J; Kvann JC; Tomaszewski M; Beaubien F; Cloutier JF; Levesque D; Sadikot AF
    Genes Brain Behav; 2013 Feb; 12(1):108-24. PubMed ID: 23006318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue-Specificity of Antibodies Raised Against TrkB and p75
    Fleury S; Boukhatem I; Le Blanc J; Welman M; Lordkipanidzé M
    Front Immunol; 2021; 12():606861. PubMed ID: 33643311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conditional ablation of brain-derived neurotrophic factor-TrkB signaling impairs striatal neuron development.
    Li Y; Yui D; Luikart BW; McKay RM; Li Y; Rubenstein JL; Parada LF
    Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15491-6. PubMed ID: 22949667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced Store-Operated Calcium Entry Leads to Striatal Synaptic Loss in a Huntington's Disease Mouse Model.
    Wu J; Ryskamp DA; Liang X; Egorova P; Zakharova O; Hung G; Bezprozvanny I
    J Neurosci; 2016 Jan; 36(1):125-41. PubMed ID: 26740655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.
    Vanhecke E; Adriaenssens E; Verbeke S; Meignan S; Germain E; Berteaux N; Nurcombe V; Le Bourhis X; Hondermarck H
    Clin Cancer Res; 2011 Apr; 17(7):1741-52. PubMed ID: 21350004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.